Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Eli Lilly Announced The Extension Of The Expiration Of The Tender Offer For POINT Biopharma Which Was Previously Scheduled To Expire On December Until December 15, 2023

Author: Benzinga Newsdesk | December 04, 2023 07:47am

Posted In: LLY PNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist